BCS class IV drugs (eg, amphotericin B, furosemide, acetazolamide, ritonavir, paclitaxel)
exhibit many characteristics that are problematic for effective oral and per oral delivery …

Nanosponges are unique sponge‐like carrier systems with numerous cavities and a mesh‐
like network throughout their surface. They are categorized into three types based on the …

Aims The effect of surface-modification of Tamoxifen (Tam)-loaded-niosomes on drug
cytotoxicity and bio-distribution, via functionalization with chitosan and/or PEGylation, was …

Design and Development of New Nanocarriers focuses on the design and development of
new nanocarriers used in pharmaceutical applications that have emerged in recent years. In …

We report the synthesis and encapsulation of polyester nanosponge particles (NPs) co-
loaded with tamoxifen (TAM) and quercetin (QT) to investigate the loading, release and in …

Neurofibromatosis type I (NF1) is an autosomal dominant disease with an incidence of
1/3000, caused by mutations in the NF1 gene, which encodes the RAS/GTPase‐activating …

The successful intracellular delivery of biologically active proteins and peptides plays an
important role for therapeutic applications. Indeed, protein/peptide delivery could overcome …

With the increasing advancement of synergistic, multimodal approaches to influence the
treatment of infectious and non-infectious diseases, we witness the development of enabling …

Serious adverse effects and low selectivity to cancer cells are the main obstacles of long
term therapy with Tamoxifen (Tmx). This study aimed to develop Tmx-loaded span-based …

The drug delivery technology landscape has become highly competitive and rapidly
evolving as more and more developments in delivery systems are being integrated to …